α-synuclein seed amplification and its uses in Parkinson's disease

Affiliations

¹ Department of Neurology, Christian Albrechts-University and University Hospital Schleswig-Holstein (Campus Kiel), Kiel, Germany. Electronic address: daniela.berg@uksh.de.
² Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein (Campus Lübeck), Lübeck, Germany.

Comment

Daniela Berg et al. Lancet Neurol. 2023 May.

. 2023 May;22(5):369-371.

doi: 10.1016/S1474-4422(23)00124-2.

¹ Department of Neurology, Christian Albrechts-University and University Hospital Schleswig-Holstein (Campus Kiel), Kiel, Germany. Electronic address: daniela.berg@uksh.de.
² Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein (Campus Lübeck), Lübeck, Germany.

No abstract available

Conflict of interest statement

We declare no competing interests.

Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C; Parkinson's Progression Markers Initiative. Siderowf A, et al. Lancet Neurol. 2023 May;22(5):407-417. doi: 10.1016/S1474-4422(23)00109-6. Lancet Neurol. 2023. PMID: 37059509 Free PMC article.